Minnow Street Minnow Street
Buy Day today: Neutral (53) Mixed market breadth · no major macro event

Bruker Corporation (BRKR)

Healthcare Medical Devices
62.80 $
-2.3% vs. previous close
Closing price · As of: 31. Jul 2026

Who owns Bruker Corporation (BRKR)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 68.0% of the shares are freely tradable; institutional investors hold 92.8%.

Ownership Structure

Institutional ownership
92.8%
Insiders
27.0%
Float
68.0%
Short % of float
18.5%
Shares Outstanding
152Mio.

Largest Shareholders

Institutions

Institutions BRKR
Name Stake (%) Shares Change (%) Date
Orbis Allan Gray Ltd 11.79 17,940,076 +20.3 03/31/2026
FMR Inc 10.58 16,101,803 +5.7 03/31/2026
BlackRock Inc 7.34 11,180,806 +1.9 03/31/2026
Pallas Capital Advisors LLC 6.23 9,481,821 +0.0 03/31/2026
Vanguard Portfolio Management, LLC 3.19 4,855,915 +0.0 03/31/2026
Vanguard Capital Management, LLC 3.16 4,817,076 +0.0 03/31/2026
State Street Corp 2.57 3,908,693 +2.0 03/31/2026

Funds

Funds BRKR
Name Stake (%) Shares Change (%) Date
Orbis Global Equity Investor 2.51 3,824,157 +23.0 03/31/2026
iShares Core S&P Mid-Cap ETF 2.51 3,816,691 +0.0 07/30/2026
Vanguard Morn Total Stk Mkt Idx Investor 2.22 3,380,776 -0.2 06/30/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
15. Jul 2026 Munch Mark EXEC VP&PRES BRUKER NANO INC. Sell 2,000 60.25 120,500
15. Jul 2026 Munch Mark EXEC VP&PRES BRUKER NANO INC. Other 2,000 22.19 44,380

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.

View all insider transactions →

Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?